OBJECTIVE: Elucidating molecular mechanisms underlying limbic epileptogenesis may reveal novel targets for preventive therapy. Studies of TrkB mutant mice led us to hypothesize that signaling through a specific phospholipase (PLC), PLCγ1, promoted development of kindling. METHODS: To test this hypothesis, we examined the development of kindling in PLCγ1 heterozygous mice. We also examined the cellular and subcellular location of PLCγ1 in adult wild-type mice. RESULTS: The development of kindling was impaired in PLCγ1 heterozygous mice compared to wild-type controls. PLCγ1 immunoreactivity was localized to the soma and dendrites of both excitatory and inhibitory neurons in the hippocampus of adult mice. SIGNIFICANCE: This study implicates PLCγ1 signaling as the dominant pathway by which TrkB activation promotes limbic epileptogenesis. Its cellular localization places PLCγ1 in a position to modify the efficacy of both excitatory and inhibitory synaptic transmission. These findings advance PLCγ1 as a novel target for therapies aimed at preventing temporal lobe epilepsy induced by status epilepticus. Wiley Periodicals, Inc.
OBJECTIVE: Elucidating molecular mechanisms underlying limbic epileptogenesis may reveal novel targets for preventive therapy. Studies of TrkB mutant mice led us to hypothesize that signaling through a specific phospholipase (PLC), PLCγ1, promoted development of kindling. METHODS: To test this hypothesis, we examined the development of kindling in PLCγ1 heterozygous mice. We also examined the cellular and subcellular location of PLCγ1 in adult wild-type mice. RESULTS: The development of kindling was impaired in PLCγ1 heterozygous mice compared to wild-type controls. PLCγ1 immunoreactivity was localized to the soma and dendrites of both excitatory and inhibitory neurons in the hippocampus of adult mice. SIGNIFICANCE: This study implicates PLCγ1 signaling as the dominant pathway by which TrkB activation promotes limbic epileptogenesis. Its cellular localization places PLCγ1 in a position to modify the efficacy of both excitatory and inhibitory synaptic transmission. These findings advance PLCγ1 as a novel target for therapies aimed at preventing temporal lobe epilepsy induced by status epilepticus. Wiley Periodicals, Inc.
Authors: Guoping Fu; Yuhong Chen; Mei Yu; Andy Podd; James Schuman; Yinghong He; Lie Di; Maryam Yassai; Dipica Haribhai; Paula E North; Jack Gorski; Calvin B Williams; Demin Wang; Renren Wen Journal: J Exp Med Date: 2010-02-01 Impact factor: 14.307
Authors: Q S Ji; G E Winnier; K D Niswender; D Horstman; R Wisdom; M A Magnuson; G Carpenter Journal: Proc Natl Acad Sci U S A Date: 1997-04-01 Impact factor: 11.205
Authors: Liliana Minichiello; Anna Maria Calella; Diego L Medina; Tobias Bonhoeffer; Rüdiger Klein; Martin Korte Journal: Neuron Date: 2002-09-26 Impact factor: 17.173
Authors: Beatrice Paradiso; Peggy Marconi; Silvia Zucchini; Elena Berto; Anna Binaschi; Aleksandra Bozac; Andrea Buzzi; Manuela Mazzuferi; Eros Magri; Graciela Navarro Mora; Donata Rodi; Tao Su; Ilaria Volpi; Lara Zanetti; Andrea Marzola; Roberto Manservigi; Paolo F Fabene; Michele Simonato Journal: Proc Natl Acad Sci U S A Date: 2009-04-06 Impact factor: 11.205
Authors: Eva M Jimenez-Mateos; Tobias Engel; Paula Merino-Serrais; Ross C McKiernan; Katsuhiro Tanaka; Genshin Mouri; Takanori Sano; Colm O'Tuathaigh; John L Waddington; Suzanne Prenter; Norman Delanty; Michael A Farrell; Donncha F O'Brien; Ronán M Conroy; Raymond L Stallings; Javier DeFelipe; David C Henshall Journal: Nat Med Date: 2012-07 Impact factor: 53.440